Your browser doesn't support javascript.
loading
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
Razavi, Pedram; Chang, Matthew T; Xu, Guotai; Bandlamudi, Chaitanya; Ross, Dara S; Vasan, Neil; Cai, Yanyan; Bielski, Craig M; Donoghue, Mark T A; Jonsson, Philip; Penson, Alexander; Shen, Ronglai; Pareja, Fresia; Kundra, Ritika; Middha, Sumit; Cheng, Michael L; Zehir, Ahmet; Kandoth, Cyriac; Patel, Ruchi; Huberman, Kety; Smyth, Lillian M; Jhaveri, Komal; Modi, Shanu; Traina, Tiffany A; Dang, Chau; Zhang, Wen; Weigelt, Britta; Li, Bob T; Ladanyi, Marc; Hyman, David M; Schultz, Nikolaus; Robson, Mark E; Hudis, Clifford; Brogi, Edi; Viale, Agnes; Norton, Larry; Dickler, Maura N; Berger, Michael F; Iacobuzio-Donahue, Christine A; Chandarlapaty, Sarat; Scaltriti, Maurizio; Reis-Filho, Jorge S; Solit, David B; Taylor, Barry S; Baselga, José.
Afiliação
  • Razavi P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Chang MT; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Xu G; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Bandlamudi C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Ross DS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Vasan N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Cai Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Bielski CM; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Jonsson P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Penson A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Pareja F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kundra R; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Middha S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Cheng ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kandoth C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Patel R; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Huberman K; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Smyth LM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Modi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Traina TA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Dang C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Zhang W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Ladanyi M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Schultz N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Robson ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hudis C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Viale A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Norton L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Dickler MN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Berger MF; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Iacobuzio-Donahue CA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Scaltriti M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Reis-Filho JS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Solit DB; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, Ne
  • Taylor BS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kette
  • Baselga J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: baselgaj@mskcc.org.
Cancer Cell ; 34(3): 427-438.e6, 2018 09 10.
Article em En | MEDLINE | ID: mdl-30205045

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias da Mama Masculina / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Sistema de Sinalização das MAP Quinases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias da Mama Masculina / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Sistema de Sinalização das MAP Quinases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos